NUC-7738

DB19148InvestigationalSmall molecule

NUC-7738 is under investigation in clinical trial NCT03829254 (A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma).

Formula / weight: C₂₆H₂₉N₆O₇P · 568.527 g/mol (avg)
Also known as: Fosdesdenosine Sipalabenamide · L-Alanine, N-(3′-deoxy-P-phenyl-5′-adenylyl)-, phenylmethyl ester (ACI)
Code names: NUC-7738

Resolves to

Compound

UNIIY7BFN2M72FCAS2348493-39-8ChEMBLCHEMBL5277528

Structure

InChIKeyUDLWWGQHMQIYCV-LKKHFEEPSA-NSMILESC[C@H](NP(=O)(OC[C@@H]1C[C@@H](O)[C@@H](O1)N1C=NC2=C(N)N=CN=C12)OC1=CC=CC=C1)C(=O)OCC1=CC=CC=C1

What you can answer from here — as of August 31, 2026

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of NUC-7738, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account